about
Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin binding.Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set.The Effect of CM082, an Oral Tyrosine Kinase Inhibitor, on Experimental Choroidal Neovascularization in Rats.Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.Ranibizumab: A Review of Its Use in the Treatment of Diabetic Retinopathy in Patients With Diabetic Macular Edema.
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Current perspectives on ranibizumab
@ast
Current perspectives on ranibizumab
@en
Current perspectives on ranibizumab
@nl
type
label
Current perspectives on ranibizumab
@ast
Current perspectives on ranibizumab
@en
Current perspectives on ranibizumab
@nl
prefLabel
Current perspectives on ranibizumab
@ast
Current perspectives on ranibizumab
@en
Current perspectives on ranibizumab
@nl
P2860
P3181
P356
P1476
Current perspectives on ranibizumab
@en
P2093
Sophie Bakri
Vaidehi Dedania
P2860
P304
P3181
P356
10.2147/OPTH.S80049
P407
P577
2015-03-20T00:00:00Z